MPS Pharmaa Limited (BOM:531686)
1.810
0.00 (0.00%)
At close: Jun 15, 2026
MPS Pharmaa Revenue
In the fiscal year ending March 31, 2026, MPS Pharmaa had annual revenue of 356.00K INR, down -25.40%. MPS Pharmaa had revenue of 356.00K in the quarter ending March 31, 2026, with 174,409.80% growth.
Revenue
356.00K
Revenue Growth
-25.40%
P/S Ratio
97.17
Revenue / Employee
19.78K
Employees
18
Market Cap
34.59M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 356.00K | -121.20K | -25.40% |
| Mar 31, 2025 | 477.20K | -459.47K | -49.05% |
| Mar 31, 2024 | 936.67K | 703.67K | 302.00% |
| Mar 31, 2023 | 233.00K | -94.46K | -28.85% |
| Mar 31, 2022 | 327.46K | - | - |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Vivanza Biosciences | 1.16B |
| Fabino Enterprises | 208.41M |
| Beryl Drugs | 188.20M |
| Brawn Biotech | 169.78M |
| Unjha Formulations | 157.49M |
| Decipher Labs | 142.75M |
| Norris Medicines | 81.32M |
| Ganga Pharmaceuticals | 28.28M |